Argenx
ARGX
$360.23
Share price
0.51%
Change (1 day)
-5.78%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Argenx (ARGX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.44 B
According to Argenx 's latest financial reports the company's total liabilities are $0.44 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Argenx - Total liabilities on balance sheet (from 2021 to 2020)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.32 B | 1.43% |
| 2021-12-31 | $0.31 B | -57.55% |
| 2020-12-31 | $0.74 B | 54.64% |
| 2019-12-31 | $0.48 B | 818.38% |
| 2018-12-31 | $52.42 M | 40.13% |
| 2017-12-31 | $37.41 M | -20.3% |
| 2016-12-31 | $46.93 M | 352.17% |
| 2015-12-31 | $10.38 M | -16.71% |
| 2014-12-31 | $12.46 M | 97.59% |
| 2013-12-31 | $6.3 M | -24.04% |
| 2012-12-31 | $8.3 M | 58.5% |
| 2011-12-31 | $5.23 M | 94.14% |
| 2010-12-31 | $2.69 M |